On the other hand, downstream Wnt inhibitors targeting the β-catenin-TCF4 transcription complex (CCT036477, iCRT14, and PKF118-310) preferentially eliminated MCL-ICs over MCL-non-ICs. Here, TCF4 is linked to mantle cell lymphoma.